(Q53455433)

English

Induction Chemotherapy and Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Patients With Locally Advanced Inoperable Non–Small-Cell Lung Cancer: The MRC INCH Randomized Trial

scientific article published on October 6, 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20932667

Induction Chemotherapy and Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Patients With Locally Advanced Inoperable Non–Small-Cell Lung Cancer: The MRC INCH Randomized Trial (English)

reason for preferred rank

most precise value

1 reference

10.1016/J.IJROBP.2010.06.053

https://api.crossref.org/works/10.1016/J.IJROBP.2010.06.053

29 July 2024

Induction chemotherapy and continuous hyperfractionated accelerated radiotherapy (chart) for patients with locally advanced inoperable non-small-cell lung cancer: the MRC INCH randomized trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20932667

29 July 2024

adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

6

object named as

Neal Navani

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20932667

29 July 2024

author name string

Matthew Hatton

1

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20932667

Matthew Nankivell

2

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20932667

Ethan Lyn

3

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20932667

Stephen Falk

4

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20932667

Cheryl Pugh

5

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20932667

Richard Stephens

7

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20932667

Mahesh Parmar

8

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20932667

language of work or name

0 references

publication date

6 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20932667

full work available at URL

https://api.elsevier.com/content/article/PII:S0360301610009089?httpAccept=text/xml

1 reference

10.1016/J.IJROBP.2010.06.053

https://api.crossref.org/works/10.1016/J.IJROBP.2010.06.053

29 July 2024

https://api.elsevier.com/content/article/PII:S0360301610009089?httpAccept=text/plain

1 reference

10.1016/J.IJROBP.2010.06.053

https://api.crossref.org/works/10.1016/J.IJROBP.2010.06.053

29 July 2024

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20932667

81

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20932667

3

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20932667

712-718

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20932667

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1

1 reference

10.1016/J.IJROBP.2010.06.053

https://api.crossref.org/works/10.1016/J.IJROBP.2010.06.053

29 July 2024

Comparison of surgery and radiation therapy for non-small cell carcinoma of the lung with mediastinal metastasis

2

1 reference

10.1016/J.IJROBP.2010.06.053

https://api.crossref.org/works/10.1016/J.IJROBP.2010.06.053

29 July 2024

Radiotherapy employing three fractions on each of twelve consecutive days

4

1 reference

10.1016/J.IJROBP.2010.06.053

https://api.crossref.org/works/10.1016/J.IJROBP.2010.06.053

29 July 2024

Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee

5

1 reference

10.1016/J.IJROBP.2010.06.053

https://api.crossref.org/works/10.1016/J.IJROBP.2010.06.053

29 July 2024

Fatal pulmonary fibrosis associated with induction chemotherapy with carboplatin and vinorelbine followed by CHART radiotherapy for locally advanced non-small cell lung cancer

7

1 reference

10.1016/J.IJROBP.2010.06.053

https://api.crossref.org/works/10.1016/J.IJROBP.2010.06.053

29 July 2024

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

9

1 reference

10.1016/J.IJROBP.2010.06.053

https://api.crossref.org/works/10.1016/J.IJROBP.2010.06.053

29 July 2024

The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials

10

1 reference

10.1016/J.IJROBP.2010.06.053

https://api.crossref.org/works/10.1016/J.IJROBP.2010.06.053

29 July 2024

Patient-reported short-term and long-term physical and psychologic symptoms: results of the continuous hyperfractionated accelerated [correction of acclerated] radiotherapy (CHART) randomized trial in non-small-cell lung cancer. CHART Steering Commi

13

1 reference

10.1016/J.IJROBP.2010.06.053

https://api.crossref.org/works/10.1016/J.IJROBP.2010.06.053

29 July 2024

Long term results of surgery versus continuous hyperfractionated accelerated radiotherapy (CHART) in patients aged >70 years with stage 1 non-small cell lung cancer

15

1 reference

10.1016/J.IJROBP.2010.06.053

https://api.crossref.org/works/10.1016/J.IJROBP.2010.06.053

29 July 2024

Routine use of continuous, hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer: a five-center experience

16

1 reference

10.1016/J.IJROBP.2010.06.053

https://api.crossref.org/works/10.1016/J.IJROBP.2010.06.053

29 July 2024

Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-c

17

1 reference

10.1016/J.IJROBP.2010.06.053

https://api.crossref.org/works/10.1016/J.IJROBP.2010.06.053

29 July 2024

[CHARTWEL-Bronchus (ARO 97-1): a randomized multicenter trial to compare conventional fractionated radiotherapy with CHARTWEL radiotherapy in inoperable non-small-call bronchial carcinoma]

18

1 reference

10.1016/J.IJROBP.2010.06.053

https://api.crossref.org/works/10.1016/J.IJROBP.2010.06.053

29 July 2024

GRiN: a trial and tribulation in respiratory radiotherapy research

19

1 reference

10.1016/J.IJROBP.2010.06.053

https://api.crossref.org/works/10.1016/J.IJROBP.2010.06.053

29 July 2024

Lung cancer treatment waiting times and tumour growth

21

1 reference

10.1016/J.IJROBP.2010.06.053

https://api.crossref.org/works/10.1016/J.IJROBP.2010.06.053

29 July 2024

High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non–small-cell lung cancer: Long-term results of a radiation dose escalation study

22

1 reference

10.1016/J.IJROBP.2010.06.053

https://api.crossref.org/works/10.1016/J.IJROBP.2010.06.053

29 July 2024

Dose escalation of chart in non-small cell lung cancer: is three-dimensional conformal radiation therapy really necessary?

23

1 reference

10.1016/J.IJROBP.2010.06.053

https://api.crossref.org/works/10.1016/J.IJROBP.2010.06.053

29 July 2024

Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B.

24

1 reference

10.1016/J.IJROBP.2010.06.053

https://api.crossref.org/works/10.1016/J.IJROBP.2010.06.053

29 July 2024

Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology

25

1 reference

10.1016/J.IJROBP.2010.06.053

https://api.crossref.org/works/10.1016/J.IJROBP.2010.06.053

29 July 2024

Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 S

26

1 reference

10.1016/J.IJROBP.2010.06.053

https://api.crossref.org/works/10.1016/J.IJROBP.2010.06.053

29 July 2024

Identifiers

10.1016/J.IJROBP.2010.06.053

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20932667

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20932667

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53455433&oldid=2215598846"